Bidirectional relationship between temporomandibular disorder and ankylosing spondylitis: a population-based cohort study

• Published in: Clinical oral investigations 2021-11, Vol.25 (11), p.6377-6384
• Main Authors: Huang, Yi-Fang, Chang, Chung-Ta, Muo, Chih-Hsin, Chiu, Kuan-Ming, Tsai, Chun-Hao, Liu, Shih-Ping
• Format: Article
• Language: English
• Subjects: Ankylosing spondylitis; Arthritis; Cohort analysis; Comorbidity; Cushing syndrome; Dentistry; Gender; Medicine; Original Article; Osteoporosis; Patients; Population studies; Population-based studies; Rheumatoid arthritis
• ISSN: 1432-6981; 1436-3771
• DOI: 10.1007/s00784-021-03938-0

Objectives This study aimed to determine the relation between temporomandibular disorder (TMD) and ankylosing spondylitis (AS) bidirectionally and ascertain the important comorbidities for AS occurrence in TMD patients. Materials and methods We conducted this population-based cohort study through Longitudinal Health Insurance Database, Taiwan. Study 1 investigated the risk of TMD in AS patients. Study 2 assessed the risk of AS in TMD patients. Results In total, 3204 AS patients and 12,816 age-matched and gender-matched comparisons were enrolled in study 1. The TMD incidence in the AS cohort was 2.88-fold higher when compared with the comparisons (1.54 vs. 0.53 per 10,000 person-years). After adjusting for age, gender, and comorbidity, the AS cohort had a 2.66-fold (95% CI = 1.79–3.97) increased risk of TMD occurrence ( P < 0.0001). The second study recruited 4998 TMD patients and 19,991 age-matched and gender-matched comparisons. Both TMD and comparison cohorts showed similar AS risk (HR = 1.49, 95% CI = 0.91–2.43, P = 0.1108) in the adjusted model. Study 2 identified a 3.66-fold increased risk of AS occurrence in TMD patients with comorbidity, including parapsoriasis, rheumatoid arthritis, osteoporosis, Cushing’s syndrome, and climacteric arthritis ( P < 0.012). Conclusions AS appears to significantly impact the occurrence of TMD. TMD might play a synergic role in AS development. Clinical relevance Clinicians have to be vigilant about the increased risk of TMD in AS patients and take care of AS disease activity and prognosis. The symptoms and signs of TMD could be a predictor of AS in patients with the aforementioned comorbidities.